Form 4: Analog Devices CEO Exercises Options, Sells Shares
Insider Transaction Report
Analog Devices CEO Vincent Roche exercised stock options and subsequently sold 10,000 shares of common stock on January 2, 2026, under a pre-arranged 10b5-1 plan.
Summary
- Vincent Roche, Chair & CEO of Analog Devices Inc. (ADI), reported transactions involving the company's common stock.
- On January 2, 2026, Mr. Roche acquired 10,000 shares of common stock by exercising non-qualified stock options at a price of $94.41 per share.
- Concurrently, Mr. Roche disposed of 10,000 shares of common stock at a price of $275.07 per share.
- The sale was executed pursuant to a Rule 10b5-1 trading plan adopted on May 23, 2025.
- Following these transactions, Mr. Roche directly beneficially owns 155,688.462 shares of common stock.
- Additionally, 23,515 shares are indirectly beneficially owned through the Vincent Roche 2024 Grantor Retained Annuity Trust.
Sentiment
Score: 5
Explanation: The filing reports a routine insider transaction involving the exercise of stock options and subsequent sale of shares under a pre-arranged 10b5-1 plan. This is a common practice for executive compensation and does not inherently indicate a positive or negative sentiment regarding the company's future prospects.
Positives
- The exercise of stock options and subsequent sale indicates the monetization of vested equity compensation, which is a common practice for executives.
- The sale was conducted under a pre-arranged Rule 10b5-1 plan, which helps mitigate concerns about opportunistic insider trading.
Negatives
- The sale of shares by a CEO, even if pre-planned, can sometimes be perceived by some investors as a lack of confidence, though it is a routine part of executive compensation and financial planning.
Future Outlook
NA
Industry Context
NA
Related Party Transactions
- 23,515 shares of common stock are indirectly beneficially owned by Vincent Roche through the Vincent Roche 2024 Grantor Retained Annuity Trust, dated October 3, 2024.
Stakeholder Impact
- Shareholders: The transaction is a routine insider sale under a 10b5-1 plan, which typically has minimal direct impact on other shareholders. It represents an executive monetizing vested equity compensation.
- Employees: No direct impact on employees is indicated by this transaction.
Key Dates
| Date | Description |
|---|---|
| 03/15/2021 | Date when the non-qualified stock option became fully vested and exercisable. |
| 10/03/2024 | Date of the Vincent Roche 2024 Grantor Retained Annuity Trust. |
| 05/23/2025 | Date the Rule 10b5-1 plan was adopted by the Reporting Person. |
| 01/02/2026 | Date of the stock option exercise and subsequent sale transaction. |
| 01/05/2026 | Date the Form 4 was signed by Shelly Shaw, General Counsel, by Power of Attorney. |
| 03/11/2030 | Expiration date of the non-qualified stock option. |
Keywords
Analog Devices, ADI, Vincent Roche, Form 4, Insider Transaction, Stock Option Exercise, Equity Sale, 10b5-1 Plan, CEO
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.